Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:2504058.
doi: 10.1155/2017/2504058. Epub 2017 Feb 6.

The Benefit of Neuromuscular Blockade in Patients with Postanoxic Myoclonus Otherwise Obscuring Continuous Electroencephalography (CEEG)

Affiliations

The Benefit of Neuromuscular Blockade in Patients with Postanoxic Myoclonus Otherwise Obscuring Continuous Electroencephalography (CEEG)

Christopher R Newey et al. Crit Care Res Pract. 2017.

Abstract

Introduction. Myoclonus status epilepticus is independently associated with poor outcome in coma patients after cardiac arrest. Determining if myoclonus is of cortical origin on continuous electroencephalography (CEEG) can be difficult secondary to the muscle artifact obscuring the underlying CEEG. The use of a neuromuscular blocker can be useful in these cases. Methods. Retrospective review of CEEG in patients with postanoxic myoclonus who received cisatracurium while being monitored. Results. Twelve patients (mean age: 53.3 years; 58.3% male) met inclusion criteria of clinical postanoxic myoclonus. The initial CEEG patterns immediately prior to neuromuscular blockade showed myoclonic artifact with continuous slowing (50%), burst suppression with myoclonic artifact (41.7%), and continuous myogenic artifact obscuring CEEG (8.3%). After intravenous administration of cisatracurium (0.1 mg-2 mg), reduction in artifact improved quality of CEEG recordings in 9/12 (75%), revealing previously unrecognized patterns: continuous EEG seizures (33.3%), lateralizing slowing (16.7%), burst suppression (16.7%), generalized periodic discharges (8.3%), and, in the patient who had an initially uninterpretable CEEG from myogenic artifact, continuous slowing. Conclusion. Short-acting neuromuscular blockade is useful in determining background cerebral activity on CEEG otherwise partially or completely obscured by muscle artifact in patients with postanoxic myoclonus. Fully understanding background cerebral activity is important in prognostication and treatment, particularly when there are underlying EEG seizures.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Effect of cisatracurium on continuous electroencephalography (CEEG). (a) The CEEG is completely obscured by myogenic artifact. After neuromuscular blockade, generalized continuous slowing is seen. (b) Myogenic artifact obscured the CEEG. After neuromuscular blockade, generalized slowing along with lateralized right slowing is seen. (c) Rhythmic myogenic artifact partially obscured the CEEG. After neuromuscular blockade, 3 Hz generalized periodic discharges were seen consistent with nonconvulsive status epilepticus.
Figure 2
Figure 2
Effect of filtering continuous electroencephalography (CEEG) compared to cisatracurium. CEEG is partially obscured by myogenic artifact filtered at (a) 70 Hz, (b) 50 Hz, (c) 30 Hz, (d) 15 Hz, and (e) 5 Hz compared to neuromuscular blockade (f). This patient had asymmetric burst suppression (decreased left hemisphere).

Similar articles

Cited by

References

    1. Koenig M. A., Kaplan P. W., Thakor N. V. Clinical neurophysiologic monitoring and brain injury from cardiac arrest. Neurologic Clinics. 2006;24(1):89–106. doi: 10.1016/j.ncl.2005.11.003. - DOI - PubMed
    1. Safar P. Cerebral resuscitation after cardiac arrest: a review. Circulation. 1986;74(6):138–152. - PubMed
    1. Levy D. E., Caronna J. J., Singer B. H., Lapinski R. H., Frydman H., Plum F. Predicting outcome from hypoxic-lschemic coma. The Journal of the American Medical Association. 1985;253(10):1420–1426. doi: 10.1001/jama.1985.03350340072020. - DOI - PubMed
    1. Wijdicks E. F. M., Parisi J. E., Sharbrough F. W. Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Annals of Neurology. 1994;35(2):239–243. doi: 10.1002/ana.410350219. - DOI - PubMed
    1. Wijdicks E. F. M., Hijdra A., Young G. B., Bassetti C. L., Wiebe S. Practice parameter: Prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;67(2):203–210. doi: 10.1212/01.wnl.0000227183.21314.cd. - DOI - PubMed

LinkOut - more resources